2023-02-03 07:35:13 CBOE Cboe Global Markets
02/03/23 02/0307:35 02/03/2307:35 | Cboe Global Markets sees FY23 CapEx $60M-$66MCboe provided guidance for the FY23: Sees FY23 organic total net revenue growth 7%-9%, above medium-term organic total net revenue guidance expectations of 5%-7%; revenue from acquisitions held less than a year is expected to contribute total net revenue growth of 0.5% points in 2023; organic net revenue from Data and Access Solutions is expected to increase by approximately 7%-10% in 2023, in line with medium-term guidance expectations; adjusted operating expenses in 2023 are expected to be $769M-$779M, from a base of $652M in 2022. The guidance excludes the expected amortization of acquired intangible assets of $112M; the company plans to reflect the exclusion of this amount in its non-GAAP reconciliation. Depreciation and amortization expense for 2023, which is included in adjusted operating expenses above, is expected to be in the range of $48M-$52M, excluding the expected amortization of acquired intangible assets. Other income net, is expected to contribute a $27M-$33M benefit in 2023 given expected performance of minority investments. The effective tax rate on adjusted earnings for the FY23 is expected to be in the range of 28.5%-30.5%. Significant changes in trading volume, expenses, tax laws or rates and other items could materially impact this expectation. Capital expenditures for 2023 are expected to be $60M-$66M. |
|
---|
Hot Stocks
|
Puma presents biomarker findings from Phase II study in HR+, TN breast cancer »
09:08 06/04/23 06/0409:08 06/04/2309:08
PBYI
Puma Biotechnology
Puma Biotechnology… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Amgen presents new LUMAKRAS CodeBreaK 200 CNS data at ASCO »
08:48 06/04/23 06/0408:48 06/04/2308:48
AMGN
Amgen
Amgen announced the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Bristol-Myers presents follow-up results from Phase 3 CheckMate -9LA trial »
08:45 06/04/23 06/0408:45 06/04/2308:45
BMY
Bristol-Myers
Bristol-Myers Squibb… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
ImmunoGen presents results Phase 3 confirmatory MIRASOL trial »
08:41 06/04/23 06/0408:41 06/04/2308:41
IMGN
ImmunoGen
ImmunoGen announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Summit presents data for investigational bispecific antibody ivonescimab »
08:28 06/04/23 06/0408:28 06/04/2308:28
SMMT
Summit Therapeutics
Summit Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
AstraZeneca says TAGRISSO achieved 'unprecedent' survival in EGFRm »
08:24 06/04/23 06/0408:24 06/04/2308:24
AZN
AstraZeneca
AstraZeneca says… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
G1 Therapeutics presents data from Phase 2 study of trilaciclib in TNBC »
07:28 06/04/23 06/0407:28 06/04/2307:28
GTHX
G1 Therapeutics
G1 Therapeutics presented… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Saudi Arabia, some OPEC members clash over production quotas, WSJ reports »
06:37 06/04/23 06/0406:37 06/04/2306:37
BP
BP
ConocoPhillips
Shell
TotalEnergies
Exxon Mobil
Chevron
Saudi Arabia and some… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Bank stocks too beaten down, JPMorgan among those to buy now, Barron's says »
06:29 06/04/23 06/0406:29 06/04/2306:29
JPM
JPMorgan
Citizens Financial
The past three months saw… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Ride not over for Eaton stock, Barron's says »
06:25 06/04/23 06/0406:25 06/04/2306:25
ETN
Eaton
A year ago, the backlog… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
IBM hiding in plain sight, paying big dividend, Barron's says »
06:21 06/04/23 06/0406:21 06/04/2306:21
IBM
IBM
IBM is one of the most… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Twitter loses another senior executive in charge of content, safety, WSJ says »
17:46 06/03/23 06/0317:46 06/03/2317:46
TWTR
A second senior executive… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announces updated data from Phase 2 TRiMM-2 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen presents analysis of infections, parameters in Monumen-TAL1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announced results from Phase 1/2 MonumenTAL-1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune Group announces 3 trial-in-progress abstracts at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Additional Abstracts… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents data from Phase 1 trial of RP2 with nivolumab at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune Group (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents RP1 data from IGNYTE trial at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
| Healthcare Analysts hold… Story temporarily locked. |
Hot Stocks
|
Janssen announces results from Phase 1b RedirecTT-1 study »
17:18 06/03/23 06/0317:18 06/03/2317:18
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Evaxion's trial of EVX-01 met its primary endpoints of safety, tolerability »
17:09 06/03/23 06/0317:09 06/03/2317:09
EVAX
Evaxion Biotech
Evaxion Biotech presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gracell presents long-term follow up data from study evaluating GC012F »
17:07 06/03/23 06/0317:07 06/03/2317:07
GRCL
Gracell
Gracell Biotechnologies… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Sutro Biopharma announces results from Phase 1 dose-expansion study of luvelta »
17:02 06/03/23 06/0317:02 06/03/2317:02
STRO
Sutro Biopharma
Sutro Biopharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Equitrans Midstream's Mountain Valley Pipeline to proceed »
16:58 06/03/23 06/0316:58 06/03/2316:58
ETRN
Equitrans Midstream
On June 3, 2023, the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cogent Biosciences announces data from ongoing Phase 3 PEAK trial »
16:56 06/03/23 06/0316:56 06/03/2316:56
COGT
Cogent Biosciences
Cogent Biosciences… Story temporarily locked. ShowHide Related Items >><<
|